New research, guidelines and FDA decisions, each with a note on what it might change in a conversation with your surgeon, how certain it is, and links to the original sources.
How we choose news. Nothing here is sponsored. Mentioning a product isn't an endorsement, and an FDA clearance means a device was found substantially equivalent to existing ones, not proven better. Updated November 2026.
FDA
FDA approves Synergy Disc for one-level cervical disc replacement
The FDA approved Synergy Spine Solutions' Synergy Disc, an artificial cervical disc with a built-in angled core, for single-level use from C3 to C7. A two-level study is ongoing.
What this could change in a conversation with your surgeon: It's another disc replacement option. Ask whether you're a candidate for disc replacement at all, and why your surgeon prefers one device.
Disc replacement didn't significantly cut reoperations vs fusion at 7 years
A registry study in Spine of more than 6,000 patients followed for nearly seven years found one-level cervical disc replacement didn't significantly reduce reoperations for neighboring-level problems or for any cause compared with ACDF.
What this could change in a conversation with your surgeon: The main hoped-for advantage of disc replacement is still unproven in the long run. Both remain reasonable options.
Business, product and professional-society developments. Useful background, but less likely to change your own decision.
Industry
Synergy Disc two-year results presented
Company-reported two-year data from the Synergy Disc approval study showed higher composite clinical success than an older ACDF comparison group, with greater improvement in neck disability.
What this could change in a conversation with your surgeon: The comparison group came from a separate, earlier trial, which makes head-to-head conclusions weaker than a randomized trial. Ask your surgeon how they weigh it.
